Hypophosphatemia Risk Associated With Intravenous Iron Therapies For Iron Deficiency Anemia

The purpose of this study was to systematically assess rates of treatment-emergent hypophosphatemia among IDI formulations used in IDA.

Authors

Lim-Watson M, Libre M, Karkare S, Alkhateeb Z, Hadker N, Bajic-Lucas A, Dahl N, Strauss W, Glaspy J

Journal

ISPOR Meeting, May 2019

See all Thought Leadership posts